Larubis, Berlyn T.

HRN: 21 97 69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2022
CEFUROXIME 1.5GM (VIAL)
11/28/2022
12/05/2022
INTRAVENOUS
750 Mg
Q8h
Prophylaxis

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: